Legal Representation
Attorney
Lisa L. Mueller
USPTO Deadlines
Next Deadline
1553 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-10-24)
Due Date
October 24, 2029
Grace Period Ends
April 24, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 1, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Mar 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Mar 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Mar 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Mar 1, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Oct 24, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 24, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Aug 8, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 8, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 19, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jul 6, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
Jun 30, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
Jun 29, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 29, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 29, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 29, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 29, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 31, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 24, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 21, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations to treat Crohn's Disease for human use; biologic preparations for medical and therapeutic purposes to treat Chron's disease, inflammatory diseases and disorders, diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis
Classification
International Classes
005